The PIO II study of in-office placement of a steroid-eluting sinus implant

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
Randomized, controlled, blinded clinical trial with 40 patients randomized in a 1:1 ratio to either treatment (bilateral in-office placement of a drug-eluting implant in the ethmoid sinuses following ethmoidectomy) or control (post-op standard of care) group and followed for 6 months.
Epistemonikos ID: ab7e4debcfcf92dcf8533b26123a9af843eb7998
First added on: May 12, 2024